What is HCSG's 12-month price target and RQD AI Jury consensus?

HCSG's 12-month base price target is $27.5 (range $21.12 to $32.45), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Stock Ratings / Health Care / HCSG

SNDA (31) ARDT (69) MD (77) BKD (32) ⌘ Pro Terminal →

Healthcare Services Group Inc. (HCSG) — RQD Stock Rating Cockpit

Q: Should I buy, hold, or sell HCSG stock right now?

Healthcare Services Group Inc. (HCSG) currently earns a Roarable Rating of B (Buy — BUY) with 73/100 RQD Confidence. High-quality cash engine (13.0% gross margin, 12% return on capital) with steady institutional support.

$25.76 +5.06% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $26.06

Healthcare Services Group Inc. (HCSG) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (13.0% gross margin, 12% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $1.65B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HCSG Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HCSG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Healthcare Services Group Inc. (NASDAQ: HCSG) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $25.76 (+5.06% 1D, market cap $1.65B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 15/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 15/20. Across 1015 tracked Health Care issuers, HCSG ranks #50 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HCSG compare to SNDA and ARDT in the Health Care sector?

▼

Within the Health Care sector (Hospital/Nursing Management), HCSG carries a Roarable B (73/100 RQD), trailing P/E of 28.2x, gross margin of 13.0%, and ROIC of 11.6%. By comparison, SNDA (Sonida Senior Living Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC —, cap $1.65B) and ARDT (Ardent Health Inc.) posts a C+ grade (69/100 RQD, P/E 12.8x, ROIC 10.5%, cap $1.70B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HCSG?

▼

Per HCSG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000731012), Healthcare Services Group Inc. generated $1.84B in revenue (+7.1% YoY), $59.1M in net income, and $139.2M in free cash flow against $794.3M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (13.0% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $26.06 (+1.15%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 7.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 73/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.1% avg 90D alpha vs SPY • 69.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+6.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HCSG)Realized 20D OHLCV Swing Band: ±7.3%

Deterministic 5-Pillar Attribution (73/100 Composite)

🔍 WHY HCSG SCORES 73/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+16/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 7.6% FCF Margin ($139.2M FCF) & 13% Gross Margin

▲ #2 Bullish Driver: Whale & Options Positioning+16/20 pts (22% of score)

20D Institutional Volume Accumulation (±7.3% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit11/20 pts (-9 pt drag)

Macro rate sensitivity & RSI-14 (66.2) create a -9 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$20.89+2.9% Next Q

Q2 (-2Q)

Grade B-$21.50+13.3% Next Q

Q3 (-1Q)

Grade B$24.37+5.7% Next Q

Current

Grade B$25.76+7.1% Hist 90D α

Trajectory: C+ (65) → B (73)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HCSG Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 73/100 (B) score, HCSG faces multiple-compression risk if 28.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 15.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($22.05) or 200D SMA ($21.46) invalidates the momentum regime and cuts Target Base ($27.50) toward Bear Floor ($21.12).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HCSG• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HCSG Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 73%NO 27%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

66.230 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

7 / 99-Pt Accounting

52-WEEK LASER RANGE99% OF RANGE

L: $17$25.76H: $26

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (13.0% gross margin and healthy balance-sheet cushion).

Factor Grade: B+RQD 16 / 20

2. Big Money & Insiders● BUYING

Are whales & executives buying or selling?

Hedge funds and options traders are leaning bullish, showing strong institutional appetite.

Factor Grade: B+RQD 31 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: CRQD 26 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bullish on HCSG

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (80)

11.6% ROIC with 13.0% gross margin and 8.36% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (75)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BULLISH (70)

31/40 institutional & smart-money positioning score with 11/20 macro alignment.

Bull Case: Why Buyers Like HCSG

✓Strong cash generator (13.0% gross margin)—profits are backed by real money, not accounting tricks.
✓Big institutional funds and options desks are actively positioning on the bullish side.
✓Company leadership has skin in the game with net positive insider conviction.

Bear Case: What Could Go Wrong

!Broader market pullbacks can still drag down strong stocks in the short run.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HCSG Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HCSG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +22.03%▲ RESISTANCE BREAKOUT

2026-11-03O $24.68H $25.76L $24.52C $25.76VOL 635.0K

RES: $24.06SUP: $19.89SMA50: $22.05SMA200: $21.46

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HCSG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HCSG Butterfly Map → + Track HCSG →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

21.6%/yr Implied 5Y Growth

vs. +7.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HCSG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HCSG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HCSG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HCSG)

Health Care Rank #50 of 1015 ⚔️ SNDA vs HCSG Full Matrix →

1. Head-to-Head Health Care Peer Comparison (HCSG vs. SNDA, ARDT, MD, BKD)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Healthcare Services Group Inc. (HCSG) ranks #50 by composite RQD confidence (73/100, grade B) and #286 by equity capitalization ($1.65B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with HCSG at 73/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HCSG ACTIVE Healthcare Services Group Inc.	B	73/100	28.2x	13.0%	11.6%	+5.06%	$1.65B	Benchmark Subject
SNDA Sonida Senior Living Inc.	E	31/100	—	—	—	-1.25%	$1.65B	/snda-vs-hcsg →
ARDT Ardent Health Inc.	C+	69/100	12.8x	—	10.5%	-2.49%	$1.70B	/ardt-vs-hcsg →
MD Pediatrix Medical Group Inc.	B+	77/100	14.3x	—	33.6%	+2.99%	$2.33B	/md-vs-hcsg →
BKD Brookdale Senior Living Inc.	E	32/100	—	26.2%	0.3%	+0.48%	$2.48B	/bkd-vs-hcsg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000731012 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Healthcare Services Group Inc. (HCSG) reported GAAP revenue of $1.84B (+7.1% vs. FY2024 revenue of $1.72B , and +9.9% cumulative change since FY2023) , GAAP net income of $59.1M, operating cash flow of $145.0M, and free cash flow of $139.2M (+468.7% YoY). On the balance sheet, HCSG closed FY2025 with $794.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.84B	$59.1M	$145.0M	$139.2M	$794.3M	—
FY2024 (FY)	2024-12-31	$1.72B	$39.5M	$30.8M	$24.5M	$802.8M	—
FY2023 (FY)	2023-12-31	$1.67B	$38.4M	$43.5M	$43.5M	—	—

3. HCSG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HCSG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does HCSG compare to SNDA and ARDT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for HCSG?

Where is HCSG trading relative to its 50-day, 200-day, and 52-week technical levels?

HCSG last traded at $25.76 (+5.06% on volume of 671,987 shares), positioning the stock +16.83% above its 50-day simple moving average ($22.05) and +20.04% above its 200-day simple moving average ($21.46). Across its 52-week range of $16.78 to $25.75, HCSG sits at the 100.0% percentile with a 14-day RSI of 66.2 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.3% ($23.88 to $27.64).

Direct Sub-Reports: HCSG RQD Cockpit HCSG 12M Forecast HCSG Earnings & Move HCSG Dividends & DRIP HCSG Insiders & 13F HCSG Whale Options HCSG Profit Sankey HCSG News & Why

ROARABLE RATING BRIEF • RQD 73/100 (B) ✓ SEC XBRL & RQD VERIFIED

HCSG — Healthcare Services Group Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Healthcare Services Group Inc. (HCSG) earns a live Roarable RQD composite score of 73/100, corresponding to a B letter grade (Roarable Buy) at a spot price of $25.76 (+5.06% 1D, market capitalization $1.65B).

Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of 11.6%, gross margin of 13.0%, operating margin of —, and free cash flow yield of 8.36%.
Whale 13F & Options Flow (16/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (11/20) + Forensic Balance Sheet (15/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 7/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Healthcare Services Group Inc. (HCSG) is a NASDAQ-listed issuer in the Health Care sector, within the Hospital/Nursing Management industry. The source data reports FY 2025 revenue of $1.84B (). — for further business-model detail.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Healthcare Services Group Inc. (HCSG) reported $1.84B in annual revenue (up from $1.72B in FY2024, +7.1% YoY) and $59.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.67B revenue, $38.4M net income) through FY2025, HCSG scaled operating cash flow to $145.0M and free cash flow to $139.2M, backed by $794.3M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (B • RQD 73/100): Strong cash generator (13.0% gross margin)—profits are backed by real money, not accounting tricks. Big institutional funds and options desks are actively positioning on the bullish side. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 16/20, sustained execution supports upside toward the upper end of the $16.78 – $25.75 52-week range.
🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 28.2x trailing P/E against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies cannot be mapped from the source data. The only sector context available is the Health Care sector and Hospital/Nursing Management industry classification. — for sector correlation metrics, 2nd-order bottlenecks, or specific customer or supplier concentration.

Key Question #1: Can HCSG sustain or expand its — operating margin and 11.6% ROIC against Hospital/Nursing Management peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $1.84B and free cash flow of $139.2M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is HCSG's 26.2x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

HCSG Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Healthcare Services Group Inc. (HCSG) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HCSG Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 21h ago

Healthcare Services Group, Inc. (HCSG) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 1d ago

Healthcare Services Group: Adding To A Non-Convincing Story (NASDAQ:HCSG)

Seeking Alpha report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

Healthcare Services Group Gears Up for Q3 Earnings: What's in Store?

TradingView report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Is Healthcare Services (HCSG) a Solid Growth Stock? 3 Reasons to Think "Yes"

Yahoo Finance report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 1d ago

Healthcare Services Group Is Cleaning Up, But It's Not Ready For Another Upgrade (HCSG)

Seeking Alpha report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance Singapore • 1d ago

Is Healthcare Services Group (HCSG) Stock Outpacing Its Business Services Peers This Year?

Yahoo Finance Singapore report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Why Healthcare Services Group Stock Is In Focus After Growth Outlook Lifted

Yahoo Finance report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Healthcare Services (HCSG) Q3 Earnings Surpass Estimates

Yahoo Finance report covering Healthcare Services Group Inc. (HCSG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HCSG Bull vs. Bear Conversation Board — What's Your Call at $25.76?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HCSG 🐻 33% BEARISH CONVICTION

TA TapeReader_Pro RQD DEBATE OPENER • Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $30.90 (+26.0%)

📌 Pinned Debate

The stock generates an 8.36% FCF yield and 11.6% ROIC while revenue grew from $1.67B to $1.84B over FY 2023–FY 2025.

Long HCSG at $24.52 targeting $30.90. The stock generates an 8.36% FCF yield and 11.6% ROIC while revenue grew from $1.67B to $1.84B over FY 2023–FY 2025.. Institutional whale score is 16/20 and the risk/reward vs. the $16.78 52-week low is skewed heavily in favor of bulls.

EarningsSniper 🐂 BULL

@CreditSpread_Watch Shorting a 16/20 institutional whale-flow stock at $24.52 is dangerous when funds are rotating into Health Care.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $18.39 (-25.0%)

Spot @ $24.52

The stock trades at a 28.2 trailing P/E with a 3.2% net margin, a 0% operating margin, and an 11/20 macro fit score tied to a beta of 1

I respect the product at Healthcare Services Group Inc., but the stock at $24.52 is a different story. The stock trades at a 28.2 trailing P/E with a 3.2% net margin, a 0% operating margin, and an 11/20 macro fit score tied to a beta of 1.0.. FCF yield is 8.36% and RQD sits at 73/100 (B) — why pay up here when you can wait for next quarter's numbers?